Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review

There is an unmet need for novel non-invasive prognostic molecular tumour markers for breast cancer (BC). Accumulating evidence shows that miR-155 plays a pivotal role in tumorigenesis. Generally, miR-155 is considered an oncogenic miRNA promoting tumour growth, angiogenesis and aggressiveness of BC...

Full description

Bibliographic Details
Main Authors: Anna Maria Grimaldi, Silvia Nuzzo, Gerolama Condorelli, Marco Salvatore, Mariarosaria Incoronato
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/16/5834
_version_ 1797558160373841920
author Anna Maria Grimaldi
Silvia Nuzzo
Gerolama Condorelli
Marco Salvatore
Mariarosaria Incoronato
author_facet Anna Maria Grimaldi
Silvia Nuzzo
Gerolama Condorelli
Marco Salvatore
Mariarosaria Incoronato
author_sort Anna Maria Grimaldi
collection DOAJ
description There is an unmet need for novel non-invasive prognostic molecular tumour markers for breast cancer (BC). Accumulating evidence shows that miR-155 plays a pivotal role in tumorigenesis. Generally, miR-155 is considered an oncogenic miRNA promoting tumour growth, angiogenesis and aggressiveness of BC. Therefore, many researchers have focused on its <i>use</i> as a <i>prognostic</i> biomarker and therapeutic target. However, its prognostic value for BC patients remains controversial. To address this issue, the present systematic review aims to summarize the available evidence and give a picture of a prognostic significance of miR-155 in BC pathology. All eligible studies were searched on PubMed and EMBASE databases through various search strategies. Starting from 289 potential eligible records, data were examined from 28 studies, comparing tissue and circulating miR-155 expression levels with clinicopathological features and survival rates in BC patients. We discuss the pitfalls and challenges that need to be assessed to understand the power of miR-155 to respond to real clinical needs, highlighting the consistency, robustness or lack of results obtained to sate in translating this molecule to clinical practice. Our paper suggests that the prognostic role of miR-155 in the management of BC needs to be further verified.
first_indexed 2024-03-10T17:27:35Z
format Article
id doaj.art-924deeb6d6c3436886f55c6265a0f924
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T17:27:35Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-924deeb6d6c3436886f55c6265a0f9242023-11-20T10:08:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-08-012116583410.3390/ijms21165834Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic ReviewAnna Maria Grimaldi0Silvia Nuzzo1Gerolama Condorelli2Marco Salvatore3Mariarosaria Incoronato4IRCCS SDN, Via Emanuele Gianturco 113, 80143 Naples, ItalyIRCCS SDN, Via Emanuele Gianturco 113, 80143 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, “Federico II” University of Naples, Via Pansini 5, 80131 Naples, ItalyIRCCS SDN, Via Emanuele Gianturco 113, 80143 Naples, ItalyIRCCS SDN, Via Emanuele Gianturco 113, 80143 Naples, ItalyThere is an unmet need for novel non-invasive prognostic molecular tumour markers for breast cancer (BC). Accumulating evidence shows that miR-155 plays a pivotal role in tumorigenesis. Generally, miR-155 is considered an oncogenic miRNA promoting tumour growth, angiogenesis and aggressiveness of BC. Therefore, many researchers have focused on its <i>use</i> as a <i>prognostic</i> biomarker and therapeutic target. However, its prognostic value for BC patients remains controversial. To address this issue, the present systematic review aims to summarize the available evidence and give a picture of a prognostic significance of miR-155 in BC pathology. All eligible studies were searched on PubMed and EMBASE databases through various search strategies. Starting from 289 potential eligible records, data were examined from 28 studies, comparing tissue and circulating miR-155 expression levels with clinicopathological features and survival rates in BC patients. We discuss the pitfalls and challenges that need to be assessed to understand the power of miR-155 to respond to real clinical needs, highlighting the consistency, robustness or lack of results obtained to sate in translating this molecule to clinical practice. Our paper suggests that the prognostic role of miR-155 in the management of BC needs to be further verified.https://www.mdpi.com/1422-0067/21/16/5834microRNAmiR-155breast cancerprognosisdiagnosistissue
spellingShingle Anna Maria Grimaldi
Silvia Nuzzo
Gerolama Condorelli
Marco Salvatore
Mariarosaria Incoronato
Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
International Journal of Molecular Sciences
microRNA
miR-155
breast cancer
prognosis
diagnosis
tissue
title Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
title_full Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
title_fullStr Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
title_full_unstemmed Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
title_short Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
title_sort prognostic and clinicopathological significance of mir 155 in breast cancer a systematic review
topic microRNA
miR-155
breast cancer
prognosis
diagnosis
tissue
url https://www.mdpi.com/1422-0067/21/16/5834
work_keys_str_mv AT annamariagrimaldi prognosticandclinicopathologicalsignificanceofmir155inbreastcancerasystematicreview
AT silvianuzzo prognosticandclinicopathologicalsignificanceofmir155inbreastcancerasystematicreview
AT gerolamacondorelli prognosticandclinicopathologicalsignificanceofmir155inbreastcancerasystematicreview
AT marcosalvatore prognosticandclinicopathologicalsignificanceofmir155inbreastcancerasystematicreview
AT mariarosariaincoronato prognosticandclinicopathologicalsignificanceofmir155inbreastcancerasystematicreview